amorchem header logo close button Menu
arrow leftBack to news

Announcement of Sweet 16 Selection for the 1st edition of Sweet Pharma Day

Organizers are pleased to announce the 16 presenting startup and small biotech companies for the 1st edition of Sweet Pharma Day, selected by the large pharma companies invited to the event, here below.

(alphabetic order)

1) 99andBeyond
2) Endogena Therapeutics
3) Giiant
4) Glysantis
5) Immune Biosolutions
6) ImmunoBiochem
7) Inversago
8) JenThera
9) Mediphage Bioceuticals
10) MIMS
11) Monogenic Pharma
12) MyX Therapeutics
13) SemaThera
14) Tatum Bioscience
15) Translatum Medicus*
16) Virica

Translatum Medicus will not attend the event. StemAxon has been selected as last presenting company of Sweet 16.

Gold Sponsors: Merck & Co, Fonds de solidarité FTQ, Robic. Silver Sponsor: RBC

ABOUT SWEET PHARMA DAY.
The Sweet Pharma Day (www.sweetpharmaday.com) is an invitation-only event in life sciences in Canada, taking place in the Greater Montreal area. Its first edition is organized and supported by AmorChem, BIOTECanada, BIOQuébec, Life Sciences British Columbia, Montreal InVivo and Montreal International. It provides small biotech CEOs to closely interact with the global division of large pharma companies and key venture capital funds with a unique opportunity to build future collaborations and partnerships with the sweet pleasure of maple syrup.

Media contact:

Maxime Ranger, PhD MBA
General Partner, AmorChem
Co-chair of Sweet Pharma Day
E: mranger@amorchem.com